Source: Annual Congress 2006 - Clinical problems: miscellaneous
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Samira, I. Aissa, S. Farhati, Z. Moatemri, F. Makki, A. Khattab, H. Ghadira (Ariana, Tunisia). Place of azoles in the treatment of allergic bronchopulmonary candidiasis. Eur Respir J 2006; 28: Suppl. 50, 410

Member's Comments

No comment yet.

Related content which might interest you: Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 432s Year: 2001 Living with allergic bronchopulmonary aspergillosis Source: Breathe, 15 (2) 108; 10.1183/20734735.0170-2019 Year: 2019 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations Source: Eur Respir Rev 2014; 23: 149-152 Year: 2014 Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Treating allergic bronchopulmonary aspergillosis: the way forward Source: Eur Respir J 2016; 47: 385-387 Year: 2016 Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018 Year: 2018 Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis Source: Eur Respir Rev 2010 19: 349-351 Year: 2010 A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J 2016; 47: 490-498 Year: 2016 Allergic bronchopulmonary aspergillosis and other fungal diseases Source: Eur Respir Mon 2011; 52: 97-114 Year: 2011 Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2009 - Airways remodelling Year: 2009